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The PerC protein of enteropathogenic Escherichia coli (EPEC), encoded by the pEAF plasmid, is an activator
of the locus of enterocyte effacement (LEE) pathogenicity island via the LEE1 promoter. It has been assumed
that the related LEE-containing pathogen enterohemorrhagic E. coli (EHEC) lacks PerC-dependent activation
due to utilization of an alternative LEE1 promoter and lack of a perC gene. However, we show here that EPEC
PerC can activate both the EPEC and EHEC LEE1 promoters and that the major transcriptional start site is
similarly located in both organisms. Moreover, a PerC-like protein family identified from EHEC genome
analyses, PerC1 (also termed PchABC), can also activate both promoters in a manner similar to that of EPEC
PerC. The perC1 genes are carried by lambdoid prophages, which exist in multiple copies in different EHEC
strains, and have a variable flanking region which may affect their expression. Although individual perC1
copies appear to be poorly expressed, the total perC1 expression level from a strain encoding multiple copies
approaches that of perC in EPEC and may therefore contribute significantly to LEE1 activation. Alignment of
the protein sequences of these PerC homologues allows core regions of the PerC protein to be identified, and
we show by site-directed mutagenesis that these core regions are important for function. However, purified
PerC protein shows no in vitro binding affinity for the LEE1 promoter, suggesting that other core E. coli
proteins may be involved in its mechanism of activation. Our data indicate that the nucleoid-associated protein
IHF is one such protein.
Pathogenic bacterial strains such as enteropathogenic Esch-
erichia coli (EPEC) and enterohemorrhagic Escherichia coli
(EHEC), which cause disease by forming intestinal attaching-
and-effacing (A/E) lesions, possess a chromosomal pathoge-
nicity island (PAI) called the locus of enterocyte effacement
(LEE). The EPEC LEE is necessary and sufficient for forma-
tion of A/E lesions (21) and encodes a type III secretion sys-
tem, proteins secreted by this system which form a translocon
apparatus, and proteins (intimin and its translocated intimin
receptor, Tir) which mediate the intimate bacterial attachment
to host cells characteristic of the A/E lesion. Regulatory studies
on the LEE show that it is organized into five principal oper-
ons: LEE1, LEE2, and LEE3 encode the type III secretion
system plus the CesAB chaperone and the EspH effector;
LEE4 encodes the translocon proteins; and LEE5 encodes
intimin, Tir, and CesT, a chaperone for intimin (22, 35). The
promoter of the LEE1 operon is of key importance for regu-
lation of the entire PAI; the first gene of this operon encodes
Ler, a regulator related to the H-NS family of nucleoid-asso-
ciated proteins, which in turn activates the expression of LEE2,
LEE3, LEE5, and, at least to some extent in EPEC, LEE4 (10,
11, 22, 38). Given this hierarchical organization of expression,
it is apparent that factors and/or environmental conditions
which affect LEE1 expression will be able to regulate coordi-
nately the expression of the bulk of the LEE genes and hence
the A/E phenotype.
A number of core chromosomal factors and pathogen-spe-
cific regulators have been shown to affect LEE1 expression;
most of these studies have been performed on EPEC strains.
The nucleoid-associated protein H-NS, a common repressor of
virulence-related genes in gram-negative bacteria (8), nega-
tively regulates LEE1 expression; its effect is particularly ap-
parent at temperatures below 30°C (40). H-NS is also a tem-
perature-independent repressor of the LEE2 through LEE5
promoters, where its effect is overcome by the related Ler
protein (4, 35, 40), and therefore has multiple inputs into LEE
regulation. A second nucleoid-associated protein, integration
host factor (IHF), is required for efficient expression of LEE1
and interacts with the LEE1 promoter region in vitro; IHF is
required for activation of the entire LEE but acts directly only
at LEE1 (11). Yet another nucleoid-associated protein, Fis,
has been shown to be required for LEE1 expression as well,
although surprisingly, this effect did not seem to be transmitted
to all of the downstream LEE operons (13). Recent work on
mutations in the genes of the LEE from a related A/E patho-
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gen, Citrobacter rodentium, suggests that two open reading
frames (ORFs) downstream of LEE1 encode the antagonistic
LEE1 regulators GrlA and GrlR, which have an overall posi-
tive effect on LEE expression (6); these regulators are con-
served in the EPEC and EHEC LEEs and may be assumed to
function similarly in those organisms. Thus, pathogen-specific
as well as core E. coli regulators can control expression of the
LEE.
The principal pathogen-specific LEE regulator which has
been studied to date is the per locus from EPEC, which is
encoded by the EPEC-specific plasmid pEAF (14, 39). Activa-
tion by per is manifested at the LEE1 promoter, thereby acti-
vating the Ler regulatory cascade in a manner similar to that
for IHF (22). The per locus consists of three ORFs, encoding
an AraC-like activator protein, PerA, and PerB and PerC,
which do not belong to characterized protein families. Original
studies of per suggested that all three proteins might contribute
to activation both of the LEE and of the bundle-forming pilus
(bfp) operon located on pEAF (14, 39); however, more re-
cently it has become apparent that PerA alone acts directly to
autoactivate the per and bfp promoters, while PerC directly or
indirectly affects LEE1 expression in a manner which is PerA
dependent, but only because expression of PerC requires PerA
(4, 20, 29). PerC-dependent LEE1 activation functions in the
absence of other EPEC-specific factors in E. coli K-12 (29),
contrary to a previous suggestion that the PerC effect might be
indirect (4). However, in view of the fact that pEAF is not
found in EHEC strains, PerC is apparently EPEC specific,
which would confine this activation mechanism to EPEC
strains harboring this plasmid. It has been demonstrated that
both the EPEC and EHEC LEEs are activated by cell density-
dependent (“quorum”) sensing (37), and it has been specu-
lated that activation by Per helps EPEC to compensate for the
lower bacterial concentration (and hence reduced quorum-
sensing-dependent activation) in its colonization site, the small
intestine, compared to that of EHEC, the large intestine. It has
also been suggested that the difference in Per dependency
between EPEC and EHEC is linked to the use of an alternative
LEE1 promoter in EPEC, which is 169 bp upstream of that
found in EHEC (10, 37). In EPEC, the downstream promoter
mapped in EHEC has a 6-bp duplication overlapping the pro-
posed 10 region and a single-base-pair deletion between the
10 and 35 regions, while in EHEC strains, the upstream
promoter mapped in EPEC has a single-base-pair deletion just
upstream of the 35 region and a base pair change down-
stream of the transcriptional start site (10). It is assumed that
these nucleotide changes cause only the upstream promoter to
be functional in EPEC and only the downstream promoter to
function in EHEC, while Per-dependent activation is restricted
to the upstream promoter.
Here we have tested the responses of both the EPEC and
EHEC LEE1 promoters to activation by EPEC PerC, and we
find that both can be activated to similar extents by this EPEC-
specific protein. Moreover, the nucleotide differences between
the two promoter regions affect the intrinsic activity of the
promoter but not PerC-dependent activation, and reexamina-
tion of the LEE1 transcriptional start sites from both organ-
isms suggests that both use the upstream promoter as the
primary source of LEE1 expression. A subfamily of a group of
PerC-like proteins identified from the genome sequences of
EHEC strains is also able to activate EPEC and EHEC LEE1
expression, suggesting that activation of the LEE by PerC-like
proteins may also function in EHEC. Finally, homology-based
mutagenesis of PerC has allowed us to undertake an initial
structure-function study on this protein.
MATERIALS AND METHODS
Bacterial strain construction. The bacterial strains used in this study are listed
in Table 1, and the oligonucleotide primers used in their construction are shown
in Table 2. The single-copy chromosomal fusions of the EHEC LEE1 promoter
and mutated EPEC LEE1 promoters to lacZ were constructed by the method
previously used to make the EPEC LEE1-lacZ fusion (29). Briefly, an EHEC
LEE1 promoter fragment containing 24 codons of the ler gene plus 362 bp of
DNA upstream of the ATG was amplified from ZAP198 DNA with primers
LEE1A and LEE1TlF, digested with BamHI and KpnI, and cloned into the
temperature-sensitive vector pAJR36 (Table 1) to yield pIBlerEHEC-lac, with the
LEE1 promoter fused in frame to the lacZ gene. The fusion was then integrated
into the chromosome of MG1655 at the lac locus by using a derivative of
MG1655 in which the lacZ and lacY genes are replaced by a sacB kan cassette
encoding kanamycin resistance and sucrose sensitivity (Table 1). The pIBlerEHEC-
lac plasmid was transformed into MG1655 sacB kan at 30°C and then forced to
recombine into the chromosome by repeated subculturing in the presence of
chloramphenicol at 42°C for 48 h, followed by repeated subculturing at 30°C for
48 h without antibiotic selection to resolve the plasmid cointegrates. Successful
recombinants in which the LEE1-lacZ construct had replaced the chromosomal
sacB-kan cassette were then selected on agar plates containing 6% sucrose and
checked for kanamycin sensitivity, chloramphenicol sensitivity, and the absence
of plasmid DNA. Mutant derivatives of the EPEC LEE1-lacZ fusion plasmid
pIBler-lac derived by site-directed mutagenesis (see below) were recombined
into the MG1655 chromosome similarly. The hns-206::Apr and ihfA82::Tn10
alleles were transduced from the donor strains PD32 and NEC007, respectively,
into the MG1655 LEE1-lacZ fusion strain either singly or in combination by
using bacteriophage P1cml as described by Silhavy et al. (36).
Plasmid construction. Plasmids used or constructed in this study are listed in
Table 1, and again the oligonucleotide primers employed in construction are
shown in Table 2. The EHEC perC1 and perC2 genes were amplified from Sakai
stx or ZAP198 chromosomal DNA by using the primer pairs EHperC1/5–
EHperC1/3 and EHperC2/5–EHperC2/3, respectively, digested with BamHI and
HindIII, cloned into pACYC184, subsequently amplified from the pACYC184
clones with the same primers, and subcloned into pTH19kr. For construction of
arabinose-inducible derivatives of the same genes, the perC1 or perC2 ORF was
amplified from the pACYC184 clones by using primers perCEHfara and
EHperC1/3 (for SakPerC1-2), perC198fara and EHperC1/3 (for 198PerC1-1 and
198 PerC1-3), perC2fara and perC2EHrara (for SakPerC2), or perC2fara and
perC2198rara (for 198PerC2), digested with KpnI and HindIII, and cloned
downstream of the araBAD promoter in similarly digested pBAD33. A tagged
PerC derivative for expression and purification (pET30PerC) was made by am-
plifying the perC ORF from the low-copy-number perABC clone pTHperABC by
using perCex1 and perCex2, digesting with NcoI and BamHI, and cloning into
pET30b; this entire tagged ORF was also amplified with PETBADF and
PETBADR and cloned into KpnI-HindIII-digested pBAD33 to produce an
arabinose-inducible construct (pBADH6SPerC) to test the functionality of the
tagged protein.
Growth conditions and enzyme assays. For analysis of LEE1-lacZ transcrip-
tion, strains were grown at 37°C overnight in Luria-Bertani (LB) medium and
then subinoculated 1:100 into high-glucose Dulbecco’s modified Eagle medium
(DMEM) containing HEPES and lacking phenol red (catalog no. 21063-029;
Gibco-Invitrogen Corporation). The DMEM cultures were grown to mid-loga-
rithmic phase (optical density at 600 nm, 0.6) and assayed for -galactosidase
activity as described by Miller (23). Cultures were assayed in duplicate, and the
assays were repeated at least twice. Standard deviations were less than 10%.
Antibiotic selection with chloramphenicol (20 g/ml) or kanamycin (25 g/ml)
was carried out as appropriate. When arabinose-inducible derivatives of PerC or
PerC-like proteins were used, arabinose was added at a concentration of 1.0% to
overcome catabolite repression of the araBAD promoter by glucose in the me-
dium (15).
Site-directed mutagenesis of PerC and the EPEC LEE1 promoter. Site-di-
rected mutagenesis of the perC gene was performed using the pTHperABC
template, oligonucleotide primers as listed in Table 2, and a QuikChange site-
directed mutagenesis kit (Stratagene) according to the manufacturer’s instruc-
tions. Single-base-pair insertions, deletions, and substitutions in the EPEC LEE1
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promoter were also engineered by the QuikChange method using the fusion
plasmid pIBler-lac as a template and specific primers as listed in Table 2. The 6
mutation in the EPEC LEE1 promoter was constructed by outward PCR from
the pIBler-lac template using the 5-phosphate-containing primers LerPMut1
and LerPMut2, followed by digestion of template DNA with DpnI and religation.
RNA extraction, probe synthesis, and Northern blotting. Total cellular RNA
was extracted from cultures grown to mid-log phase by cell lysis in boiling REB
buffer (20 mM sodium acetate [pH 5.2], 2% sodium dodecyl sulfate, 0.3 M
sucrose) followed by phenol extraction and DNase I treatment as described
previously (28). A 143-bp internal HincII-PvuII fragment of the EHEC perC1
gene was cloned into the in vitro transcription vector pSPT18 to generate
pSPTperC1. This plasmid and the previously described plasmid pSPTperC (Ta-
ble 1) were linearized with HindIII and transcribed in vitro with SP6 RNA
polymerase to generate digoxigenin-UTP-labeled RNA probes by using a DIG-
RNA labeling kit supplied by Roche Molecular according to the manufacturer’s
instructions. Samples of total cellular RNA (20 g) were electrophoresed on
morpholinepropanesulfonic acid (MOPS)-formaldehyde-agarose gels, trans-
ferred to positively charged Hybond-N membranes (Amersham), and hybrid-
ized with the labeled RNA probes overnight. Following stringency washes, bound
probes were detected with alkaline phosphatase-conjugated anti-digoxigenin and
the chemiluminescent substrate CSPD (Roche Molecular) as described previ-
ously (28). Transcript bands were quantified by using ImageQuant software.
5 RACE analysis of LEE1 transcripts. Total cellular RNA preparations from
EPEC strain E2348/69 and EHEC strain ZAP198 grown to mid-logarithmic
TABLE 1. E. coli strains and plasmids used in this study
Strain or plasmid Description Reference or source
Strains
BL21(DE3)/pLysS Expression strain with IPTG-inducible T7 RNA polymerase Novagen
DH5	 recA cloning strain Our stocks
E2348/69 Wild-type EPEC O127:H6 19
Sakai stx stx derivative of EHEC O157:H7 strain Sakai 30
MG1655 LEE1-lacZ MG1655 with chromosomal LEE1EPEC-lacZ fusion at lac 29
MG1655 LEE1EHEC-lacZ MG1655 with chromosomal LEE1EHEC-lacZ fusion at lac This work
MG1655 LEE16-lacZ MG1655 LEE1-lacZ with 6 mutation in LEE1 promoter This work
MG1655 LEE1I1-lacZ MG1655 LEE1-lacZ with I1 mutation in LEE1 promoter This work
MG1655 LEE16I1-lacZ MG1655 LEE1-lacZ with 6 and I1 mutations in LEE1 promoter This work
MG1655 LEE1C3A-lacZ MG1655 LEE1-lacZ with C3A mutation in LEE1 promoter This work
MG1655 LEE1T-lacZ MG1655 LEE1-lacZ with T mutation in LEE1 promoter This work
MG1655 LEE1C3A T-lacZ MG1655 LEE1-lacZ with C3A and T mutations in LEE1 promoter This work
MG1655 LEE16I1 C3A-lacZ MG1655 LEE1-lacZ with 6, I1, and C3A mutations in LEE1 promoter This work
MG1655 LEE16I1 T-lacZ MG1655 LEE1-lacZ with 6, I1, and T mutations in LEE1 promoter This work
MG1655 LEE16I1 C3A T-lacZ MG1655 LEE1-lacZ with 6, I1, C3A, and T mutations in LEE1 promoter This work
MG1655 LEE1-lacZ hns MG1655 LEE1-lacZ hns-206::Apr This work
MG1655 LEE1-lacZ ihf MG1655 LEE1-lacZ ihfA82::Tn10 This work
MG1655 LEE1-lacZ hns ihf MG1655 LEE1-lacZ hns-206::Apr ihfA82::Tn10 This work
MG1655 sacB kan MG1655 with lacZY replaced by sacB kan 29
NEC007 BL21(DE3) ihfA82::Tn10 12
PD32 MC4100 hns-206::Apr 7
ZAP198 EHEC O157:H7 stx Nalr 26, 32
Plasmids
pAC198PerC1-1 perC1-1 plus flanking DNA from ZAP198 in pACYC184 This work
pAC198PerC1-3 perC1-3 plus flanking DNA from ZAP198 in pACYC184 This work
pAC198PerC2 perC2 plus flanking DNA from ZAP198 in pACYC184 This work
pACSakPerC1-2 perC1-2 plus flanking DNA from Sakai stx in pACYC184 This work
pACSakPerC2 perC2 plus flanking DNA from Sakai stx in pACYC184 This work
pACYC184 P15A replicon; Cmr Tcr New England Biolabs
pAJR36 Temperature-sensitive vector, promoterless lacZ gene flanked by lacIA; Cmr 29
pBAD198PerC1-1 Arabinose-inducible PerC1-1 from ZAP198 This work
pBAD198PerC1-3 Arabinose-inducible PerC1-3 from ZAP198 This work
pBAD198PerC2 Arabinose-inducible PerC2 from ZAP198 This work
pBAD33 Arabinose-inducible expression vector; Cmr 15
pBADSakPerC1-2 Arabinose-inducible PerC1-2 from Sakai stx This work
pBADSakPerC2 Arabinose-inducible PerC2 from Sakai stx This work
pBADH6SPerC Arabinose-inducible His6-S-tagged EPEC PerC This work
pBADPerC Arabinose-inducible EPEC PerC 29
pET30b T7-controlled His6-S-tagged expression vector; Km
r Novagen
pET30PerC T7-controlled His6-S-tagged EPEC PerC This work
pIBler-lac EPEC LEE1 promoter fused in frame with lacZ in pAJR36 29
pIBlerEHEC-lac EHEC LEE1 promoter fused in frame with lacZ in pAJR36 This work
pSPT18 SP6/T7 in vitro transcription vector; Apr Roche Molecular
pSPTperC Internal fragment of EPEC perC in pSPT18 29
pSPTperC1 Internal fragment of EHEC perC1 in pSPT18 This work
pTH19kr Low-copy-number cloning vector; Kmr 16
pTH198PerC1-1 perC1-1 plus flanking DNA from ZAP198 in pTH19kr This work
pTH198PerC1-3 perC1-3 plus flanking DNA from ZAP198 in pTH19kr This work
pTH198PerC2 perC2 plus flanking DNA from ZAP198 in pTH19kr This work
pTHSakPerC1-2 perC1-2 plus flanking DNA from Sakai stx in pTH19kr This work
pTHSakPerC2 perC2 plus flanking DNA from Sakai stx in pTH19kr This work
pTHperABC EPEC perABC plus flanking DNA in pTH19kr 29
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phase in DMEM or LB medium (see above) were used as templates for first-
strand cDNA synthesis employing a SMART rapid amplification of cDNA ends
(RACE) kit (BD Biosciences) as described by the manufacturer, except that the
oligo(dT) primer supplied with the kit was replaced with the LEE1-specific
primer RACE3, which primes from 229 bp downstream of the ler initiation
codon. RACE PCR was then performed with the kit-specific universal primer
mix and the LEE1-specific RACE4 primer, and nested PCR on these products
was carried out using nested universal primer A from the kit and the RACE5
primer, which primes from 194 bp downstream of the ler initiation codon. These
steps were performed as described by the kit manufacturer, except that annealing
temperatures of 60 and 50°C, respectively, were used. Products were analyzed on
3% Agarose-MS (molecular screening agarose) gels (Roche Molecular), and
individual bands were purified from the gels and sequenced directly by using the
LEE1AR primer.
Protein purification and mobility shift assays. Five-hundred-milliliter cultures
of BL21(DE3)/pLysS transformed with pET30PerC were grown to mid-log
phase (optical density at 600 nm, 0.6) in LB medium under kanamycin selec-
tion (50 g/ml) and then induced with isopropyl--D-thiogalactopyranoside
(IPTG) at a concentration of 1 mM for 3 h. Cells were pelleted by centrifugation,
washed in 40 ml of 50 mM HEPES–0.1 M NaCl, and resuspended in 15 ml of
His-Tag binding buffer (5 mM imidazole, 0.25 M NaCl, 20 mM Tris [pH 7.9],
10% glycerol, 0.1% Triton X-100, 10 mM -mercaptoethanol). Following cell
lysis by sonication (MSE Soniprep 150; 3 to 6 pulses of 1 min at an amplitude of
5 m, interspersed with cooling on ice), cell debris was pelleted by centrifugation
at 30,000 
 g for 20 min, and the cleared supernatants were loaded onto columns
of Ni2-nitrilotriacetic acid agarose (QIAGEN) equilibrated with His-Tag bind-
ing buffer. The columns were washed twice with 15 ml of His-Tag binding buffer
supplemented with 30 mM imidazole to remove weakly bound proteins, and the
specifically bound proteins were then eluted with His-Tag binding buffer supple-
mented with 0.5 M imidazole. Eluted proteins were dialyzed against 20 mM Tris
(pH 7.9)–50 mM KCl–5 mM NaCl–1 mM EDTA–1 mM dithiothreitol–20%
glycerol–0.1% NP-40 overnight and then stored in aliquots at 80°C. EPEC
LEE1 promoter DNA fragments for use in mobility shift assays were amplified
with primer pairs LEE1A–LEE1BSf (368 to 157 with respect to the ler start
codon), LEE1BSc–LEE1AR (191 to 1), or LEE1A–LEE1AR (368 to 1)
and end labeled with digoxigenin-ddUTP by using an end-labeling kit (Roche
Molecular) according to the manufacturer’s instructions. Approximately 1.2 ng
of labeled probe was mixed with purified protein in binding buffer (10 mM Tris
[pH 7.5], 1 mM EDTA, 5 mM NaCl, 50 mM KCl, 8% glycerol, 0.05 mg of bovine
serum albumin/ml, 1 mM dithiothreitol) in the presence of a 1,000-fold excess
(1 g) of the nonspecific competitor poly(dI-dC) and was incubated at room
temperature for 20 min. Protein-DNA complexes were electrophoresed on na-
tive 4% polyacrylamide gels at 100 V and 4°C for 5 h and were then transferred
to Hybond-N membranes (Amersham). The labeled DNA probe was then
detected by using the alkaline phosphatase-CSPD-based chemiluminescence sys-
tem (Roche Molecular) as described for Northern blotting.
Computational analysis. Protein secondary-structure predictions were per-
formed at http://www.embl-heidelberg.de/predictprotein/predictprotein.html by
using the PHD algorithm (33, 34). Protein and DNA sequences were aligned by
using the BLASTP, BLASTN, and TBLASTN programs (2) at http://www.ncbi
.nlm.nih.gov/BLAST/.
RESULTS
The LEE1 promoters from both EPEC and EHEC can be
activated by PerC in the absence of other pathogen-specific
factors. In order to compare the abilities of PerC from EPEC
TABLE 2. Oligonucleotide primers used in this study
Primer Sequence (5–3)a Use
LEE1TIF cgagtggtaccCTCTATAAGCTGAATGTATGG Cloning of LEE1EHEC-lacZ fusion
LEE1A cgagtggatccGTGAAACGGTTCAGC Cloning of LEE1EHEC-lacZ fusion/bandshift
LerPMut1 pAGGAAGGACAACAATTAATCA 6 mutation of LEE1EPEC-lacZ fusion
LerPMut2 pGATAAGGTCGCTAATAGCTTT 6 mutation of LEE1EPEC-lacZ fusion
IlerPa CATTTGATTAATTGTTGgTCCTTCCTG I1 mutation of LEE1EPEC-lacZ fusion
IlerPb CAGGAAGGAcCAACAATTAATCAAATG I1 mutation of LEE1EPEC-lacZ fusion
LEEC-Aa TTACACATTAGAAAAaAGAGAATAATAACAT C3A mutation of LEE1EPEC-lacZ fusion
LEEC-Ab ATGTTATTATTCTCTtTTTTCTAATGTGTAA C3A mutation of LEE1EPEC-lacZ fusion
LEETa GGATTTTAAAAATATATGATTTTTTTGTTGACA T mutation of LEE1EPEC-lacZ fusion
LEETb TGTCAACAAAAAAATCATATATTTTTAAAATCC T mutation of LEE1EPEC-lacZ fusion
RACE3 GAGTTCCGGCGAGCGAGTCCATC RACE cDNA primer
RACE4 CGAGCGAGTCCATCATCAGGCAC RACE PCR 3 primer
RACE5 GTATATCCCAGCTCTTGTAAGG RACE PCR nested 3 primer
LEE1AR cgagtaagcttGCTTTAATATTTTAAGC Sequencing of LEE1 5 RACE products/bandshift
LEE1BSc TTGACATTTAATGATAATG LEE1 bandshift primer
LEE1BSf CTAATGTGTAAAATACATTATC LEE1 bandshift primer
EHperC1/5 cgagtggatccTTGGCAGAATAGTTGTTTGG Cloning of EHEC perC1 plus flanking DNA
EHperC1/3 cgagtaagcttAACACGACCAGAGCACCTGT Cloning of EHEC perC1 plus flanking DNA
EHperC2/5 cgagtggatccTAACACCGGACAGTCATGCG Cloning of EHEC perC2-containing ORF
EHperC2/3 cgagtaagcttACGGGCGAGAATACTCATGA Cloning of EHEC perC2-containing ORF
perCEHfara ctagcaggtaccGCAGTCTGTAGATAAACGGAG Cloning of arabinose-inducible SakPerC1-2
perC198fara ctagcaggtaccGCAGTCTGTAGATAATCGGAG Cloning of arabinose-inducible 198PerC1-1 and -3
perC2fara ctagcaggtaccGGTAATCAGCCACCAGCGGG Cloning of arabinose-inducible Sak- and 198PerC2
perC2EHrara ctagcaaagcttCCTCTGTTGTGTCTGTTTGTTTC Cloning of arabinose-inducible SakPerC2
perC2198rara ctagcaaagcttCAACTGGTGCAAAAAAAGCCGG Cloning of arabinose-inducible 198PerC2
QCC1a GGCGAAGTACTcGGAAGAAAAAGGG perC L11S mutagenesis (forward)
QCC1b CCCTTTTTCTTCCgAGTACTTCGCC perC L11S mutagenesis (reverse)
QCC2a GTACTTGGAAGAAAAAtGGTTTTATAGACGAGC perC G15W mutagenesis (forward)
QCC2b GCTCGTCTATAAAACCaTTTTTCTTCCAAGTAC perC G15W mutagenesis (reverse)
QCC3a GAAGAAAAAGGGTTTTAtATACGAGCTGCAG perC R18I mutagenesis (forward)
QCC3b CTGCAGCTCGTATaTAAAACCCTTTTTCTTC perC R18I mutagenesis (reverse)
QCC4a GGGTTTTATAGACcAGCTGCAGATC perC R19P mutagenesis (forward)
QCC4b GATCTGCAGCTgGTCTATAAAACCC perC R19P mutagenesis (reverse)
QCC6a GCGTGCATTCaGCATTAATAAATCTCTACG perC C47S mutagenesis (forward)
QCC6b CGTAGAGATTTATTAATGCtGAATGCACGC perC C47S mutagenesis (reverse)
a Sequences complementary to the target DNA are shown in capital letters; sequences unique to the oligonucleotide primer are lowercased. Restriction sites used
for cloning are underlined. p, added 5 phosphate.
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strain E2348/69 to activate the LEE1 promoters from EPEC
and EHEC, we used single-copy chromosomal fusions of the
two promoters to lacZ integrated into the genome of the E. coli
K-12 strain MG1655 at the native lac locus. The LEE1EPEC-
lacZ fusion has been described previously (29), and the
LEE1EHEC-lacZ fusion was constructed by similar methods
(see Materials and Methods). The EPEC fusion contains 368
bp of DNA upstream of the ATG of the ler gene, extending as
far as the enterobacterial repetitive intergenic consensus se-
quence found upstream of LEE1 in this organism (9); because
of differences in the promoter sequence, this corresponds to
362 bp in the EHEC fusion (Fig. 1). Each fusion also contains
the first 24 codons of ler, which are fused in frame to lacZ. Into
these two fusion strains we introduced plasmid pBADPerC, in
which the PerC protein is expressed from the arabinose-induc-
ible araBAD promoter without a requirement for its natural
activator, the AraC-like PerA protein. Compared to the vector
control, pBAD33, pBADPerC mediated 40-fold activation of
the EPEC LEE1 promoter when induced with 1.0% arabinose
in DMEM at mid-logarithmic phase (Fig. 2A). Unexpectedly,
a similar fold activation by PerC was also seen at the EHEC
LEE1 promoter, although the actual level of expression, both
unactivated and activated, from this promoter was three- to
fourfold lower than that from the EPEC promoter.
Point mutations in the EPEC LEE1 promoter that make it
more like the EHEC promoter reduce its activity but do not
affect activation by PerC. EHEC LEE1 transcription has been
postulated to be Per independent due to the use of a promoter
different from that in EPEC as a result of base changes in the
DNA upstream of the ler ORF. Around the downstream LEE1
promoter previously mapped in EHEC (37), EPEC contains
two sets of mutations, a duplication of a 6-bp sequence over-
lapping the putative 10 region and a deletion of a G nucle-
otide between the 10 and 35 regions (10) (Fig. 1). Con-
versely, around the upstream LEE1 promoter mapped in
EPEC (22), EHEC contains a C-to-A transversion 5 bp down-
stream of the transcriptional start site and a deletion of a T
nucleotide 2 bp upstream of the 35 region (Fig. 1). We
therefore introduced these changes individually and in combi-
nation into the LEE1EPEC-lacZ fusion construct on a plasmid
and recombined all the constructs into the MG1655 chromo-
some as described above. The mutated constructs were then
assayed in comparison to the native EPEC and EHEC con-
structs when the strains were grown to mid-log phase in
FIG. 1. Promoter regions of the LEE1 operon from EPEC O127:H6 and EHEC O157:H7 cloned as chromosomal LEE1-lacZ fusion constructs
in this study. The 35 and 10 regions associated with previously mapped transcriptional start sites (10, 22, 37) are boxed, and these start sites
are indicated by angled arrows. Mutations in the EPEC promoter sequence engineered in this study are indicated above the EPEC sequence.
Nucleotides identified as RNA 5 ends by 5RACE analysis are boldfaced. The first 24 amino acids of the EPEC and EHEC Ler protein sequences,
which were encoded by the fusion constructs, are indicated above and below the respective DNA sequences.
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DMEM with or without PerC-dependent activation (Fig. 2B).
The LEE1EPEC-6 and LEE1EPEC-I1 constructs with EHEC-
like mutations around the downstream promoter sequences
had slightly reduced expression, which was reduced further to
around two-thirds that of the native EPEC promoter when the
two mutations were combined (LEE1EPEC-6I1) but was still
significantly higher than that obtained from the EHEC promoter.
In comparison, single-base-pair mutations around the upstream
promoter sequences (LEE1EPEC-C3A or LEE1EPEC-T) had
slightly greater effects on expression than the 6 or I1 muta-
tion, and when the two were combined (LEE1EPEC-C3AT),
-galactosidase activity was reduced by 50%. This result sug-
gests that the upstream promoter sequences are more impor-
tant for expression than the downstream sequences, as ex-
pected in EPEC. When these upstream mutations were
combined with those around the downstream promoter se-
quences, EPEC promoter constructs with activity reduced al-
most to that of the EHEC construct were obtained (Fig. 2B).
The effect of combining the single mutations in the EPEC
promoter is therefore a stepwise reduction in activity toward
that of the EHEC promoter. The slightly elevated activity of
the quadruple-mutant construct (LEE1EPEC-6I1 C3AT) rela-
tive to that of LEE1EHEC presumably reflects the effect of the
final base difference between the two promoters, a G-to-A
transition 89 bp upstream of the EPEC transcriptional start
site (Fig. 1). It is also possible that the change of Thr to Asn at
codon 11 of the EHEC Ler protein may affect expression of
this translational fusion. Importantly, however, all of the fusion
constructs, like their EPEC and EHEC parents, were activated
similarly (around 40-fold) by expression of PerC (Fig. 2B). This
suggests either that the LEE1 promoter region in general is
activated similarly by PerC irrespective of which promoter is
functional or that the location of the LEE1 transcriptional start
sites in EPEC and EHEC strains requires reexamination.
The major transcriptional start sites of the EPEC and
EHEC LEE1 promoters map within a few base pairs of each
other. In order to verify which transcriptional start sites oper-
ate in vivo at the EPEC and EHEC LEE1 operons, we per-
formed 5-RACE analysis of LEE1 transcripts in total cellular
RNA from EPEC strain E2348/69 and EHEC strain ZAP198
grown to mid-log phase in DMEM or LB medium (see Mate-
rials and Methods for details). This methodology allows the
detection of RNA end points from within the entire LEE1
promoter region with a single set of primers, thus eliminating
inconsistencies due to variations in primer binding. Using a 3
primer amplifying from 194 bp downstream of the Ler initia-
tion codon, we obtained major products of 350 to 400 bp from
both strains in either growth medium, with the EPEC product
appearing slightly larger than the EHEC product (Fig. 3).
These sizes are consistent with the upstream start site previ-
ously mapped in EPEC (168 bp upstream of the ATG in
EPEC; 163 bp in EHEC [22]). Purification and sequencing of
these RACE products confirmed that the EPEC transcript
started at the previously identified G nucleotide or at the A
immediately downstream, while the EHEC transcript started
FIG. 2. (A) Expression of the LEE1EPEC-lacZ and LEE1EHEC-lacZ
fusion constructs in the presence of the arabinose-inducible EPEC
PerC construct pBADPerC (open bars) or the vector control pBAD33
(solid bars). Strains were grown in DMEM with 1.0% arabinose to
mid-logarithmic phase and assayed. (B) Effects of EHEC-like pro-
moter mutations on expression of the LEE1EPEC-lacZ fusion construct.
Fusion strains containing the mutations indicated (see also Fig. 1) were
assayed in the presence of pBADPerC (open bars, left-hand scale) or
pBAD33 (solid bars, right-hand scale) as described for panel A. The
unmutated LEE1EPEC-lacZ and LEE1EHEC-lacZ fusion constructs
were assayed as controls. The activated and unactivated expression
levels are plotted on different scales to enable both to be seen clearly.
FIG. 3. 5 RACE analysis of LEE1 transcripts from EPEC strain
E2348/69 and EHEC strain ZAP198 grown to mid-logarithmic phase
in DMEM or LB medium. The products were analyzed on 3% Agar-
ose-MS gels, and the positions of molecular weight markers (in base
pairs) are shown. Major and minor RACE products are indicated by
large and small arrows, respectively. The initiating nucleotides corre-
sponding to the major products are indicated in the box at the right of
the figure; those corresponding to the minor products are shown in Fig.
1.
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at a G nucleotide 7 bp downstream of the major EPEC start
(Fig. 1 and 3). Thus, it seems that essentially the same LEE1
promoter is used by both EPEC and EHEC in the strains
tested here; the apparent 7-bp difference in the initiating nu-
cleotide could be due to the EHEC-specific C-to-A transver-
sion downstream of the EPEC start site. Much weaker RACE
products of 220 bp were also obtained from both EPEC and
EHEC RNA; the abundance of the EHEC product was slightly
greater (Fig. 3). Purification and sequencing of these products
revealed in EHEC a variety of 5 ends clustered around (but
not including) the previously identified EHEC start site, and in
EPEC dual 5 ends at equivalent G residues within the 6-bp
EPEC-specific duplication (Fig. 1). This heterogeneity suggests
that these 5 ends may represent processing sites within the
LEE1 transcript rather than genuine transcriptional starts and
that the effect of the 6-bp duplication within this region of the
EPEC 5 untranslated sequence is to affect this processing
rather than to abolish an alternative promoter. Whatever the
true nature of the downstream transcript ends, it is clear that
the upstream LEE1 promoter is dominant in both organisms,
and this finding correlates with the ability of PerC to activate
both EPEC and EHEC LEE1-lacZ fusions.
PerC-homologous proteins exist in a variety of pathogenic
E. coli strains with different copy numbers. When it was first
characterized, PerC from EPEC was considered a unique pro-
tein with no known homologues in other organisms (14, 39).
Based on this assumption, the PerC-dependent activation of
the EHEC LEE1 promoter demonstrated above would be an
artifactual effect never seen in EHEC strains. However, the
complete genome sequencing of the EHEC strains EDL933
and Sakai (17, 27), of UPEC strain CFT073 (41), and even of
the E. coli K-12 laboratory strain MG1655 (3) reveals that all
of these organisms encode proteins with differing degrees of
similarity to PerC. The chromosome of the EHEC strain Sakai
encodes a total of five PerC-like proteins, all located within
prophages or prophage-like regions scattered throughout the
chromosome (Table 3 and Fig. 4). The closest relative of PerC,
which we term EHEC PerC1, is 47% identical and 67% similar
to PerC, has a 14-amino-acid nonconserved C-terminal exten-
sion, and exists in three copies encoded by the lambda-like
prophages Sp4 (PerC1-1), Sp11 (PerC1-2), and Sp14 (PerC1-
3). PerC1-1 has conservative amino acid substitutions at two
nonconserved amino acids (L6V and M58V) compared to
PerC1-3, while PerC1-2 has only the M58V substitution; the
200 bp of DNA upstream of the perC1 ORFs are also highly
divergent among the three copies, which may affect expression.
EHEC PerC2, which is 39% identical and 65% similar to PerC
and has a putative 14-amino-acid N-terminal extension which
overlaps an upstream ORF, is encoded by the nonlambdoid
Sp7 prophage. Finally, EHEC PerC3, 25% identical and 54%
similar to PerC, is found in the CP4 phage-like element SpLE1
(Table 3; Fig. 4). Since completion of this work, characteriza-
tion of the PerC1-1, -2, and -3, PerC2, and PerC3 proteins from
the Sakai strain has also been reported by Iyoda and Watanabe
(18), who termed them PchA through PchE, respectively; these
alternative designations are also shown in Table 3 and Fig. 4C.
The genome sequence of EHEC strain EDL933 reveals only a
single PerC1 protein, equivalent to PerC1-3 from Sakai and
encoded by the CP-933R lambdoid prophage, as well as a
PerC2 protein identical to that in Sakai and encoded by the
CP-933C prophage (which is equivalent to Sp7 and is inserted
at the same location) and two identical copies of the PerC3
protein due to the duplication of the SpLE1 phage-like ele-
ment in this strain (24, 27) (Table 3). However, Iyoda and
TABLE 3. PerC-homologous proteins identified from completed bacterial and phage genomes
Organism Protein Length(aa)
Database
reference
Location
(bp)
% PerC identity/
similarity (no. of
residues)
EHEC O157:H7 Sakai (NC_002695.1) EHEC PerC1-1 (PchA) 104 NP_309118.1 1183678–1183364 47/67 (87)
EHEC PerC1-2 (PchB) 104 NP_310209.1 2183078–2182764 47/67 (87)
EHEC PerC1-3 (PchC) 104 NP_310764.1 2690650–2690336 47/67 (87)
EHEC PerC2 (PchD) 104a NP_309615.1 1601592–1601906 39/65 (89)
EHEC PerC3 (PchE) 89 NP_309415.1 1439736–1440005 25/54 (81)
EHEC O157:H7 EDL933 (NC_002655.2) EHEC PerC1 104 NAc 2139131–2138823 47/67 (87)
EHEC PerC2 104a NA 1685565–1685879 39/65 (89)
EHEC PerC3-1 89 NA 1127902–1128171 25/54 (81)
EHEC PerC3-2 89 NA 1523508–1523777 25/54 (81)
UPEC CFT073 (NC_004431.1) UPEC PerC2 96a NA 1384917–1385207 42/59 (76)
UPEC PerC3 102b NP_754054.1 4962162–4961854 25/53 (86)
UPEC YfdN 164 NP_755073.1 3057063–3056569 30/48 (56)
E. coli K-12 MG1655 (NC_000913.1) YfdN 164 NP_416858.1 2470901–2470407 36/50 (46)
S. flexneri SfV phage (NC_003444.1) YfdN 162 NP_599072.1 29126–29614 32/46 (56)
Salmonella serovar Typhimurium ST64B phage
(NC_004313.1)
YfdN 174 NP_700416.1 31803–32327 32/51 (49)
a EHEC and UPEC PerC2 proteins have a putative N-terminal extension of 14 amino acids compared to database entry NP_309615.1 (shown boldfaced in Fig. 4)
which overlaps with a putative upstream open reading frame.
b UPEC PerC3 has a putative N-terminal extension of 13 amino acids compared to EHEC PerC3 proteins (shown boldfaced in Fig. 4) due to the presence of an
alternative upstream start codon.
c NA, not annotated.
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FIG. 4. (A) Schematic representation of PerC-like proteins identified in EHEC and UPEC strains, E. coli K-12, and bacteriophages SfV and
ST64B by genome studies (see Table 3 for details). The extent of the protein sequence is indicated by the horizontal line, while the more-conserved
core region corresponding to amino acids 5 to 50 of EPEC PerC is indicated by a solid box. (B) BLAST alignment of EPEC PerC with the EHEC
PerC1, PerC2, and PerC3 proteins, PerC2 from UPEC strain CFT073, and YfdN from E. coli K-12 (shown from amino acid 100 only). The PerC1
sequence from strain EDL933 (corresponding to PerC1-3 from the Sakai strain [Table 3]) is shown. Putative N-terminal extensions of EHEC
PerC2, UPEC PerC2, and UPEC PerC3 (see the text) are boldfaced. Residues identical to those in EPEC PerC are boxed in dark gray, and
conservative substitutions are boxed in light gray. Predicted secondary structure motifs are boxed above the EPEC PerC sequence (H, 	-helix; S,
-strand); L, predicted loop regions. Residues of EPEC PerC mutated by site-directed mutagenesis in this work are indicated by asterisks above
the EPEC PerC sequence. (C) Summary of the various EHEC PerC-like proteins cloned in this study and their source strains. Identical proteins
(with amino acid substitutions where appropriate) encoded by sequenced EHEC strains are listed.
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Watanabe (18) report that EDL933 also contains PerC1-1
(PchA) and PerC1-2 (PchB) proteins, although they are not
present in the database sequence.
PerC-like proteins are not restricted to EHEC strains, ei-
ther. UPEC strain CFT073 encodes single copies of PerC2 and
PerC3 within prophage 3 at phoQ and a CP4-like element at
pheU, respectively (41); the UPEC PerC3 protein has a poten-
tial N-terminal extension of 13 amino acids relative to the
EHEC PerC3s due to the presence of an alternative upstream
start codon, while UPEC PerC2 is truncated at the C terminus
with respect to all the other PerC-like proteins (Fig. 4; Table
3). Both CFT073 and E. coli K-12 (but not the EHEC strains)
also encode YfdN, a protein with a heterologous N-terminal
domain but with significant C-terminal homology to the first 70
amino acids of PerC (Fig. 4). CFT073 YfdN is encoded within
a lambdoid prophage inserted at ssrA, while in MG1655 the
yfdN gene is contained within the phage-like element KpLE1
inserted at argW (17). YfdN-like proteins are also encoded by
the Shigella flexneri bacteriophage SfV (1) and the ST64B bac-
teriophage from Salmonella enterica serovar Typhimurium
(Table 3). Alignments of the amino acid sequences of these
PerC-like proteins suggest that they have a core homologous
region extending from approximately amino acid 5 to amino
acid 50 of PerC (Fig. 4A and B), although PerC1 and PerC2 in
particular have more extensive homology over the full length
of PerC.
Comparison of PerC homologues from EHEC O157:H7
strains ZAP198 and Sakai. Given the existence of this variety
of PerC homologues in bacterial pathogens other than EPEC,
we wished to investigate the possibility that some or all of them
might mediate activation of the LEE1 promoter as seen for
EPEC PerC. Initial investigations with the PerC2 and PerC3
proteins encoded by UPEC strain CFT073 indicated that they
could not activate the EPEC LEE1-lacZ chromosomal fusion
in place of EPEC PerC (data not shown). However, consider-
ing that the UPEC PerC2 protein is truncated with respect to
EHEC PerC2 and PerC itself, it was possible that the trunca-
tion, which removes a group of amino acids conserved between
EHEC PerC2 and PerC, might have affected function. We
therefore focused our attention on the EHEC PerC1 and (full-
length) EHEC PerC2 proteins. The chromosomal DNAs of
two different EHEC O157:H7 strains—ZAP198, a stx Nalr
derivative of a strain isolated from an outbreak in Washington
State (26, 32) (Table 1), and a stx derivative of the sequenced
Sakai strain (30) (Table 1)—were used as templates for PCR
amplification with primers binding to the flanking regions of
PerC1 and PerC2 from Sakai (see Materials and Methods for
details). PerC1-specific PCR products of the expected size (650
bp) were cloned into the multicopy vector pACYC184 and
sequenced. The potential PerC1 clones revealed three different
sequences: two independent clones from ZAP198 correspond-
ing to the Sakai PerC1-3 (PchC) and Sakai PerC1-1 (PchA)
proteins, which we termed 198PerC1-3 and 198PerC1-1, respec-
tively, and a clone from the Sakai stx strain corresponding to
Sakai PerC1-2 (PchB), which we termed SakPerC1-2 (Fig. 4C).
The upstream flanking DNA of the 198PerC1-1 and Sak-
PerC1-2 clones was identical to the Sakai database entries,
except that SakPerC1-2 had a T-to-A transversion 205 bp
upstream of the PerC1-2 start codon and a T-to-G change 105
bp downstream of the stop codon (data not shown). As well as
these perC1 genes, we were also able to amplify a perC2 gene
from both ZAP198 and the Sakai stx strain by using flanking
primers. The gene encoding the ZAP198 protein (198PerC2)
was identical to the Sakai PerC2 (PchD) genome sequence, while
the gene encoding the Sakai stx strain protein (SakPerC2) had
a T-to-C transition at the first base of the PerC2 stop codon,
resulting in a protein with a 28-amino-acid extension at the C
terminus (Fig. 4C). These studies suggest that ZAP198 en-
codes at least PerC1-1 and PerC1-3 proteins as in the Sakai
strain, while strain-to-strain point mutations can also occur, as
evidenced by the stop codon mutation in PerC2 and flanking
mutations in PerC1-2 present in the Sakai stx strain. Following
sequencing, the various perC1- and perC2-containing inserts
were also subcloned into the low-copy-number vector pTH19kr.
EHEC PerC1 proteins, but not PerC2 proteins, can mediate
activation of the EPEC and EHEC LEE1 promoters. The
effects of the cloned EHEC PerC-like proteins on the chromo-
somal LEE1EPEC-lacZ and LEE1EHEC-lacZ fusions in E.
coli K-12 were then tested. Compared to a low-copy-number
clone of the EPEC per locus (pTHperABC), low-copy-
number pTH19kr-based clones of EDLPerC1-2, 198PerC1-1,
198PerC1-3, SakPerC2, and 198PerC2 mediated little or no
activation of LEE1 (Fig. 5A). This may be because unlike
EPEC perC, which is transcribed from the strong, autoacti-
vated perA promoter (20, 29), the EHEC genes are individually
poorly expressed. Provision of PerA (and PerB) in trans does
not mediate any further activation of LEE1 by these low-copy-
number perC1 and perC2 clones (our unpublished data). How-
ever, by increasing SakPerC1-2, 198PerC1-1, and 198PerC1-3
protein expression by using pACYC184-based multicopy
clones, we did obtain 20 to 125% of the activation achieved by
pTHperABC, with SakPerC1-2 having the greatest effect while
198PerC1-1 was the least active (Fig. 5B). In contrast, the
pACYC184-based PerC2 clones gave no more activation than
their low-copy-number counterparts. These data suggest that
the expression levels of the PerC1 proteins are critical to their
effects on LEE1 expression and may differ for the perC1-1,
perC1-2, and perC1-3 genes due to their variable upstream
flanking regions. To eliminate this variability, the SakPerC1-2,
198PerC1-1, and 198PerC1-3 proteins, as well as SakPerC2
and 198PerC2, were cloned downstream of the inducible
araBAD promoter in the pBAD33 vector (Table 1). For the
PerC2 constructs, both of the two potential initiator methioni-
nes (Fig. 4B) were included, as was the 28-amino-acid C-
terminal extension of SakPerC2. The abilities of these con-
structs to activate LEE1-lacZ expression following induction
with 1.0% arabinose in DMEM were then compared to that of
the EPEC pBADPerC construct and the vector control
pBAD33 (Fig. 6A). While 198PerC1-3 gave activation equiva-
lent to that of PerC, SakPerC1-2 and 198PerC1-1 gave 50 to
60% activation. This finding contrasts with the situation ob-
served with the multicopy clones, where SakPerC1-2 was most
active, and presumably reflects differences in expression due
to changes in the flanking DNA. Since 198PerC1-3 and
SakPerC1-2 are identical apart from an M58V change, with an
additional L6V change in 198PerC1-1, this line of reasoning
suggests that the substitution of valine for methionine at posi-
tion 58 adversely affects function, despite the fact that this
residue is not conserved with respect to EPEC PerC (Fig. 4B),
while the L6V change has little effect. In agreement with the
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results seen with the pTH19kr- and pACYC184-based clones,
neither of the PerC2 proteins was able to activate LEE1-lacZ
expression when expressed from the araBAD promoter (Fig.
6A).
Total perC1 transcription in EHEC strain ZAP198 is only
slightly lower than that of perC in EPEC strain E2348/69.
Based on the results described above, LEE1 activation by
PerC-like proteins in EHEC appears to depend on the PerC1
proteins, but not on PerC2 (or PerC3), of the particular EHEC
strain concerned; its extent is likely to vary depending on the
precise variants of PerC1 present, the number of copies, and
their expression dependent on changes in the upstream flank-
ing sequence. To assess how the total level of PerC1 expression
in an EHEC strain compares to that of PerC in EPEC, we
compared total perC1 transcripts in EHEC strain ZAP198
grown to mid-log phase in DMEM or LB medium with those
of perC in EPEC strain E2348/69 grown under identical con-
ditions by using probes specific for perC1 and perC, respec-
tively; to allow comparison of the levels of perC and perC1
expression, the respective gene transcribed from the araBAD
promoter was used as a control and its expression level was set
to 100% (Fig. 6B). As expected given previous knowledge of
the effect of the growth medium on the expression of EPEC
virulence genes, perC was expressed better in DMEM than in
LB medium, although not to as high a level as expression from
the araBAD promoter. In contrast, total perC1 expression in
ZAP198 (which corresponds to at least the two genes that we
have cloned) was no higher in DMEM than in LB medium.
Significantly, though, it was only slightly lower relative to ex-
pression from the araBAD promoter than was that of perC.
FIG. 5. Activation of EPEC (solid bars) and EHEC (open bars)
LEE1-lacZ fusion constructs by low-copy-number (A) or medium-
copy-number (B) clones of the SakPerC1-2, 198PerC1-1, 198PerC1-3,
SakPerC2, and 198PerC2 proteins plus flanking DNA. The PerC2
clones contain a putative operon of four genes, of which perC2 is the
third. A low-copy-number clone of the EPEC perABC locus was used
as a control. Strains were grown to mid-logarithmic phase in DMEM
and assayed.
FIG. 6. (A) Activation of EPEC (solid bars) and EHEC (open
bars) LEE1-lacZ fusion constructs by arabinose-inducible clones of the
SakPerC1-2, 198PerC1-1, 198PerC1-3, SakPerC2, and 198PerC2 min-
imal open reading frames. The vector control pBAD33 and the arabi-
nose-inducible EPEC PerC construct pBADPerC are shown as con-
trols. Strains were grown to mid-logarithmic phase in DMEM plus
1.0% arabinose and assayed. (B) Northern blot analysis of perC tran-
scription in EPEC strain E2348/69 (left panel) and perC1 transcription
in EHEC strain ZAP198 (center panel) grown to mid-logarithmic
phase in DMEM or LB medium, with transcription from E. coli
MG1655 strains harboring the arabinose-inducible pBADPerC or
pBADPerC1 plasmid grown in DMEM as a control. The amount of
total RNA loaded per lane was 20 g. The RNA transcripts are
quantified in the bar graph on the right (solid bars, perC; open bars,
perC1).
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Therefore, although EHEC strains may lack an efficient tran-
scriptional activation mechanism for their perC1-like genes
equivalent to the PerA-dependent activation of perC in EPEC,
the existence of multiple copies of perC1 in EHEC strains can
partially overcome this deficiency. Thus, although activation of
LEE1 by a PerC-like protein in EHEC may be less strong than
that in EPEC even when multiple perC1 genes are present in
the same strain, it could make a significant contribution toward
total LEE1 expression.
Homology- and structure-based mutagenesis of EPEC PerC
reveals five single-amino-acid changes which eliminate activ-
ity. The discovery of a family of related PerC-like proteins with
differential abilities to activate LEE1 expression enables the
structure-function of EPEC PerC to be probed systematically
for the first time. Previously, randomly occurring missense
mutations of PerC (I27V, L30H, R44C, D63V, K70H, and
N85S) have been observed either singly or in combination in
different EPEC strains (25), but the effects of these mutations
were not clear, since all of these strains also contain PerA
mutations and PerC function was not tested in isolation. Sec-
ondary-structure predictions based on the PerC sequence sug-
gest that the core conserved region (amino acids 5 to 50) of the
PerC family is composed of three 	-helices separated by short
loops and is separated from a further helix-loop-helix at the C
terminus by a long loop or linker region which is proline rich in
many of the homologues but not in EPEC PerC (Fig. 4B).
Based on this predicted structure and the homology within the
family, we targeted five residues within the core conserved
region by site-directed mutagenesis. A conserved leucine
within the first predicted helix, L11, was mutated to serine,
while the glycine in the loop between helices 1 and 2, G15, was
mutated to tryptophan in an attempt to disrupt this putative
loop. Two basic residues at the start of helix 2, R18 and R19,
were mutated to the hydrophobic residue isoleucine or the
helix-disrupting residue proline, respectively. Finally, the sulf-
hydryl group of the conserved cysteine 47 in helix 3 was re-
moved by mutating it to serine (all the mutations are indicated
in Fig. 4B). The effects of the mutations were tested in the
context of a low-copy-number perABC clone activating the
EPEC LEE1 promoter. All the mutated proteins were ob-
served to have lost the ability to activate LEE1-lacZ expres-
sion, yielding 300 to 650 U of -galactosidase activity (the
vector control yielded 400 U) compared to 12,500 U for the
wild-type clone. This finding suggests that these conserved
residues are essential for the stability and/or function of PerC.
Particularly interesting was the effect of the relatively conser-
vative C47S mutation. It is not clear whether this residue would
actually form disulfide bonds with another PerC monomer or a
different protein in vivo, but it is apparent that replacing the
sulfhydryl group in the side chain with a hydroxyl affects func-
tion significantly. Likewise, the importance of the putative he-
lix 1-loop-helix 2 structure (the G15W and R19P mutations), a
conserved hydrophobic residue in helix 1 (the L11S mutation),
and a basic residue in helix 2 (the R18I mutation) is estab-
lished.
LEE1 promoter DNA-PerC complexes cannot be detected in
vitro but may depend on other cellular factors in vivo. The
discovery that members of a family of PerC-related proteins
can activate LEE1 expression in both EPEC and EHEC raises
the question by what mechanism this activation occurs. The
simplest explanation is that these proteins constitute a novel
family of DNA-binding proteins that bind the LEE1 promoter
DNA and activate transcription directly. To test this possibility,
we purified EPEC PerC as a His-S peptide-tagged fusion pro-
tein in E. coli (Fig. 7A). The tagged protein was pure but
showed a tendency to break down despite the presence of
protease inhibitors throughout the procedure; the observed
smaller product was demonstrated by Western blotting with
labeled S protein to be a breakdown product of the intact
protein (data not shown). Based on the size of the breakdown
product and the predicted structure of PerC, the most likely
site of cleavage is the extended loop or linker region following
helix 3 (Fig. 4B). The functionality of the N-terminal tagged
protein was checked by expressing it from the araBAD pro-
moter in the LEE1EPEC-lacZ fusion strain (Fig. 7A); in fact,
tagged PerC mediated more activation of the fusion construct
than the untagged control. This enhanced activity might reflect
stabilization of the tagged protein compared to its untagged
parent. Despite this activity in vivo, His-S-tagged PerC was
unable to bind an EPEC LEE1 promoter fragment encompass-
ing the mapped transcriptional initiation site and upstream
regions in mobility shift assays in vitro, even at a PerC con-
centration as high as 1 M (data not shown). It was also unable
to bind either to the downstream DNA region between the
promoter and the start of the ler gene or to a larger DNA
probe comprising both the upstream and downstream frag-
ments. This result implies that either PerC does not act as a
DNA-binding protein or it binds DNA only in the presence of
other cellular factors.
To investigate the latter possibility, we examined the role of
known regulators of LEE1 expression in PerC-dependent ac-
tivation. The nucleoid-associated proteins H-NS and IHF are
known to repress and activate the EPEC LEE1 promoter,
respectively (11, 40). An hns-null mutation was seen to lead to
slight derepression of EPEC LEE1 in the absence of PerC
(Fig. 7B), a result consistent with the weak repressive effect of
H-NS at 37°C (40); this derepression was still detectable but
weaker in the presence of PerC-dependent activation. In con-
trast, a mutation in the ihfA gene encoding the 	-subunit of
IHF weakened basal expression of LEE1-lacZ and abolished
most of the PerC-dependent activation, showing not only that
IHF acts as a positive regulator of the fusion construct, as
expected (11), but also that it is required for correct activation
of the promoter by PerC. When the hns and ihf mutations were
combined, the double-mutant strain exhibited derepressed
basal LEE1 expression similar to that of the hns single mutant
but PerC-activated expression similar to that of the wild type
(Fig. 7B). Therefore, H-NS and IHF act antagonistically at the
EPEC LEE1 promoter, and PerC can activate the promoter
normally when neither nucleoid-associated protein is present.
However, activation by PerC in an hns wild-type strain exhibits
a strong dependency on IHF, a finding that suggests that IHF
may mediate a promoter conformation which either stimulates
PerC binding or brings a PerC-DNA complex into contact with
the transcriptional machinery (see Discussion). Despite this
possibility, we were still unable to detect a PerC-dependent
mobility shift of the LEE1 promoter in the presence of purified
IHF (data not shown). It is possible that additional cellular
proteins are also required for PerC to bind DNA efficiently.
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DISCUSSION
The work presented here has demonstrated that, rather than
being a specific regulatory mechanism confined to EPEC
strains, PerC-dependent activation of LEE expression via the
LEE1 promoter is functional in EHEC strains as well and may
therefore have more general importance for control of the A/E
phenotype than has previously been appreciated. This conclu-
sion is based on two principal sets of observations: (i) that the
upstream, PerC-activatable LEE1 promoter is the primary
source of transcription in both EPEC and EHEC and (ii) that
EHEC strains encode PerC-related proteins which are able to
activate this promoter as PerC itself does in EPEC. It is clear
from our 5 RACE experiments that the majority of the LEE1-
specific transcripts isolated from EPEC strain E2348/69 and
EHEC strain ZAP198 are initiating in the region previously
suggested to contain the LEE1 promoter in EPEC (22), irre-
spective of the growth medium. Interestingly, the actual initi-
ating nucleotides in the two organisms seem to be slightly
different, with those in EHEC being 6 or 7 bp, respectively,
downstream of the two positions identified in EPEC here. In
fact, the mapped initiating nucleotides in EPEC are unusually
close to the proposed 10 region of this promoter (10) (Fig.
1), and it is possible that the downstream initiating nucleotide
used in EHEC is a true alternative initiation site for RNA
polymerase binding to this promoter sequence. Alternatively,
the difference may be due to a processing event; either mech-
anism may be affected by the single base change located within
this transcript initiation region in EHEC compared to EPEC.
However, it is apparent that the same core promoter is being
utilized in both organisms.
We also detected less-abundant transcripts, with 5 ends in
the downstream region previously proposed to be the LEE1
promoter in EHEC (10, 37), in RNA samples from both or-
ganisms. The heterogeneity of these transcript ends and the
fact that none of them correlates with the initiating nucleotide
suggested previously from primer extension studies leads us to
conclude that they are more likely to represent downstream
processing products of a primary transcript from the upstream
promoter. It is also noteworthy that the core promoter se-
quences proposed for the putative downstream promoter (10)
have a very long (19-bp) spacer between the 35 and 10
regions, and the ribosome binding site proposed to be associ-
ated with this transcript actually lies downstream of the ATG
codon that is normally assumed to be the initiation codon for
the Ler protein. Our observation that point mutations around
the upstream promoter affect the activity of an LEE1-lacZ
fusion more than those around the downstream promoter also
suggests that it is the upstream promoter that is the primary
determinant of LEE1 expression; the downstream mutations
found in EHEC may affect RNA processing rather than tran-
scriptional initiation and could account for the increased abun-
dance of shorter transcripts with heterogeneous 5 ends in
EHEC.
Given these observations on the concurrency of LEE1 tran-
scriptional initiation in EPEC and EHEC, it is not surprising
that the EPEC PerC protein can mediate a similar fold acti-
vation of both promoters. Indeed, the only effect of the nucle-
FIG. 7. (A) Purification and activity of His6-S-tagged EPEC PerC. (Upper panel) A Coomassie-stained gel of samples of total soluble proteins,
the unbound Ni2-agarose column fraction in the presence of 5 mM imidazole, wash fractions in the presence of 35 mM imidazole, and the fraction
eluted with 0.5 M imidazole are shown. Intact tagged PerC (15.2 kDa) and its breakdown product are indicated by arrows. Positions of molecular
size markers are given on the left. (Lower panel) Activation of the EPEC LEE1-lacZ fusion construct by the His6-S-tagged PerC protein expressed
from the pBADH6SPerC plasmid in the presence of 1.0% arabinose, compared to activation by untagged PerC expressed from pBADPerC and
the vector control, is shown. (B) Activation of the EPEC LEE1-lacZ fusion construct by pBADPerC in the absence of induction (solid bars) or
after induction with 1.0% arabinose (open bars) in E. coli K-12 wild-type (wt), hns-206::Apr, ihfA82::Tn10, and hns-206::Apr ihfA82::Tn10 strains.
Strains were grown to mid-logarithmic phase in DMEM and assayed.
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otide differences between the two upstream regions seems to
be to make the expression of EPEC LEE1 threefold higher
than that of EHEC. The observation that both promoters can
be activated by PerC is relevant given the additional finding
that EHEC encodes PerC-like proteins which can also activate
LEE1 expression. The EHEC PerC-like protein family is ob-
viously heterogeneous, given both the information obtained
from complete genome sequencing (17, 27) and our own find-
ings here. The genome sequences reveal that the EHEC strain
Sakai encodes five PerC-like proteins of three different fami-
lies (PerC1, PerC2, and PerC3) while strain EDL933 has one
extra copy of PerC3. Although only one copy of PerC1 is
present in the EDL933 database entry (compared to three in
Sakai), it is reported that the other two PerC1 proteins are
encoded by EDL933 genomic DNA (18). Our cloning studies
on the perC1 gene family show that at least two of the PerC1
variants are present in the independently isolated strain
ZAP198, while a stx derivative of Sakai contains a PerC1-2
protein with flanking nucleotide substitutions relative to the
sequenced parental isolate. All of these proteins are chromo-
somally encoded in prophage-like sequences, giving the poten-
tial for strain-to-strain variability in their sequence and copy
number. There is also variability in the PerC2 and PerC3 pro-
teins, as illustrated by our cloning of a PerC2 protein with a
novel C-terminal extension from the Sakai stx strain and by the
duplication of the prophage-like sequence encoding PerC3 in
EDL933. These results emphasize the importance of proph-
ages in strain-to-strain variation between bacterial pathogens
(5, 24) and provide a link between this variation and the reg-
ulation of virulence phenotypes.
We demonstrate here that PerC1 proteins are able to me-
diate activation of the EPEC and EHEC LEE1 promoters in a
PerC-like manner, while PerC2 (and PerC3) seems to be in-
active. This finding correlates with the fact that PerC1 is more
closely related to PerC than is PerC2, and much more so than
PerC3 (Table 3; Fig. 4). The activating ability of an individual
PerC1 protein is dependent on both its amino acid sequence
(despite the fact that the variation in amino acid sequence
among different PerC1s is restricted to positions not conserved
in PerC) and its expression level, as shown by the different
relative activation levels obtained when the PerC1 proteins
were expressed from their native upstream regions or from the
araBAD promoter. PerC1 exists in multiple copies in EHEC
strains, and the level of total perC1 expression as assayed in
strain ZAP198, which encodes at least two copies of the pro-
tein, is only slightly lower than that of perC in EPEC strain
E2348/69. Therefore, PerC1-dependent activation of LEE1 in
EHEC has the potential to be an important effect, and indeed
Iyoda and Watanabe (18) have recently shown that individual
deletions of the pchA (perC1-1) and pchB (perC1-2) genes, or
double deletions of pchA and pchB or of pchA and pchC
(perC1-3), in the Sakai strain reduce Esp protein secretion and
adherence to HEp-2 cells via an effect on LEE1 transcription.
Interestingly, PerC1-3, deletion of which alone has no effect on
Esp secretion in the latter study, is shown here to be the most
active PerC1 protein when expressed from the araBAD pro-
moter. This finding confirms that the contribution of each
PerC1 protein to LEE1 activation in EHEC is dependent both
on the amino acid sequence of the protein and on the level of
its expression from its native promoter.
The apparently weak expression of individual perC1 genes
and the lower intrinsic activity of the EHEC LEE1 promoter
that we have demonstrated here mean that, despite the pres-
ence of multiple copies of perC1, EHEC strains may still re-
quire additional transcriptional activation mechanisms to
achieve the same degree of LEE expression as EPEC. A can-
didate for such an additional activating mechanism is the po-
tentially greater quorum-sensing-dependent activation of LEE
expression experienced by EHEC at its natural site of coloni-
zation (37). It is noteworthy that EPEC is apparently unique in
having acquired a PerC protein that is encoded not in a chro-
mosomal phage-related element but on a virulence-associated
plasmid downstream of a strong, autoactivated promoter (the
perABC promoter). This recruitment and upregulation of what
was presumably originally a phage-encoded protein may have
allowed EPEC to activate its LEE expression in host environ-
ments where quorum-sensing-dependent activation is weak.
Interestingly, although PerC is an efficient activator of LEE1
fusions in E. coli K-12 (29; this work) and can complement a
polar perA mutation in EPEC (4), loss of the pEAF plasmid
does not reduce LEE2 and LEE3 expression as would be
expected (4). One possible explanation might be the existence
of additional perC homologues in EPEC as well as EHEC. The
incomplete genome sequence of EPEC strain E2348/69 (http:
//www.sanger.ac.uk/Projects/Escherichia_Shigella/) reveals no
PerC1 proteins but a much more distantly related PerC-like
protein with a long N-terminal extension which is also found in
certain bacteriophage; however, this protein does not activate
LEE1 expression (our unpublished data). We have also been
unable to amplify a perC1 gene from E2348/69 genomic DNA
by using specific primers. It is to be hoped that completion of
the EPEC genome sequence will reveal whether this organism
also encodes other PerC-like proteins that can contribute to
LEE1 activation.
The discovery that PerC-dependent activation is not con-
fined to EPEC strains containing pEAF makes the require-
ment for some understanding of how PerC acts as an activator
more pressing. Alignments of the known PerC-related proteins
afford the opportunity to probe the structure-function charac-
teristics of these proteins in a systematic way. Our secondary-
structure predictions suggest that the well-conserved core re-
gion of the family (amino acids 5 to 50 of EPEC PerC) is likely
to adopt a 3-helix structure with intervening loop regions, and
the disruption of the first loop and second helix structure by
G15W and R19P mutations, respectively, indicates that these
structural elements are critical for functionality. Likewise, a
conserved hydrophobic side chain within the (predominantly
hydrophilic) first helix and a second conserved arginine in helix
2 (one of three in that helical element) are shown by our
mutagenesis studies to be essential. The absolutely conserved
cysteine within helix 3 is also important, as shown by the
inactivity of the C47S mutant, and the rest of this helix may
also be significant for LEE1 activation, given that this is the
major region in which EPEC PerC resembles EHEC PerC1
(which can activate LEE1) more closely than PerC2 (which
cannot). The C-terminal region of PerC is also predicted to be
predominantly helical, although it is less well conserved across
the family and, as suggested by our studies with purified PerC,
may be subject to proteolytic cleavage. Although none of the
helices composing PerC are predicted to form classical DNA-
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binding motifs such as the helix-turn-helix, the simplest expla-
nation for the ability of PerC to activate LEE1 expression is
that it acts directly as a DNA-binding protein which interacts
with the LEE1 promoter. We know from our expression stud-
ies that no other pathogen-specific proteins are required to
mediate activation by PerC, but we were unable to demon-
strate any binding of purified PerC to a LEE1 promoter frag-
ment in vitro. This could be because PerC requires additional
cellular factors present in E. coli K-12 (and presumably also in
EPEC and EHEC) to form complexes on the promoter and/or
because its complexes are not stable under the conditions of
the mobility shift assay. It is interesting in this context that
efficient activation by PerC is shown here to require the acces-
sory protein IHF. IHF binds upstream of the 35 region of the
EPEC LEE1 promoter (11) and is known to be able to intro-
duce a sharp bend of 160° or more into DNA (31). It could,
therefore, either interact with PerC itself or mediate an inter-
action between an upstream-bound PerC or PerC-dependent
complex and the core transcription machinery. We have also
shown that when the H-NS protein is absent, IHF is no longer
required for full activation by PerC; this could be because
when it is no longer constrained by bound H-NS protein, the
promoter DNA can adopt such a looped structure without the
need for the DNA-bending activity of IHF. However, inclusion
of purified IHF in a bandshift reaction with PerC on the LEE1
promoter does not permit formation of a PerC-dependent
complex on this promoter (our unpublished data). It is appar-
ent that further studies on the mechanism of PerC-dependent
activation, particularly on whether it can interact with DNA
either on its own or as part of a multiprotein complex, are
urgently required.
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